TT
Ten63 Therapeutics
United States · AI · Biotech
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Strategic | $45M | Alexandria Venture Investments — Role not disclosedBlack Opal Ventures — Role not disclosedCape Fear BioCapital — Role not disclosedChugai Venture Fund — Role not disclosedDraper Associates — Role not disclosedDuke Capital Partners — Role not disclosedGates Foundation — Role not disclosedHatteras Venture Partners — Role not disclosedK5 Global — Role not disclosedMorpheus Ventures — Role not disclosedPanorama — Role not disclosedRYSE — Role not disclosedSF Holdings — Role not disclosedYosemite — Role not disclosed |